Log in to save to my catalogue

An immunogenic model of KRAS-mutant lung cancer for study of targeted therapy and immunotherapy comb...

An immunogenic model of KRAS-mutant lung cancer for study of targeted therapy and immunotherapy comb...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2506028203

An immunogenic model of KRAS-mutant lung cancer for study of targeted therapy and immunotherapy combinations

About this item

Full title

An immunogenic model of KRAS-mutant lung cancer for study of targeted therapy and immunotherapy combinations

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2022-01

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Mutations in oncogenes such as KRAS and EGFR cause a high proportion of lung cancers. Drugs targeting these proteins cause tumour regression but ultimately fail to cure these cancers, leading to intense interest in how best to combine them with other treatments, such as immunotherapies. However, preclinical systems for studying the interaction of l...

Alternative Titles

Full title

An immunogenic model of KRAS-mutant lung cancer for study of targeted therapy and immunotherapy combinations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2506028203

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2506028203

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2020.12.22.423126